| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC3677 |
| Trial ID | NCT06150365 |
| Disease | Solid Tumor |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | KSX01 TCR-T cells |
| HLA | HLA class I |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Single Arm Clinical Study on the Safety and Efficacy of Personalized KSX01-TCRT in Patients With Advanced Solid Tumors |
| Year | 2023 |
| Country | China |
| Company sponsor | Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
| Other ID(s) | KSX01-R08-102 |
| Cohort 1 | |||||||||||
|
|||||||||||